Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SAFESKIN -- Ignore unavailable to you. Want to Upgrade?

To: Apple12 who wrote (278)	4/20/1998 5:20:00 AM
From: Ron Kline	Read Replies (1) \| Respond to of 828

I agree that Safeskin is one of the "safest" stocks you can have right now. It fits this cycle of the market to a T. Good growth company, loved by institutions, demonstrated excellent long term out -performance (up more than 500% in 5 years). If this was a tech stock I would say take some off the table, but with the kind of stable predictable earnings, there are few companies that can do better. I'm not sure I agree with $100 stock but if it happens I would not be surprised. Also just a note when inflation is very low like we have right now, good growth companies like SFSK and THRX can hold very well. So take that in consideration when you shiver how high they are. Also SFSK right now is basing which is a very nice sign to see and healthy. It's not going down, up, then down lower etc like we've all seen too many tech stocks do lately. What it means is the big boys are accumulating while the small investor thinks the party might be over. They want a discount just like all of us, and they want to grab as much from weak hands as possible.

To: Apple12 who wrote (278)	4/26/1998 12:27:00 AM
From: Alan Bershtein	Read Replies (1) \| Respond to of 828

Very bullish article on Microsoft Investor investor.msn.com Here are some excepts, but I suggest reading the article. Safeskin's products are oddly high-tech and defensible -- and the world market is both vast and largely untapped. <snip> Smith Barney analyst Melissa Wilmoth says Safeskin gloves have the lowest antigen content in the industry -- a status that helped it develop, in her opinion, the "best gloves in the world." The firm has developed substantial contracts with such organizations as Columbia/HCA (COL) and several other top health-care organizations and wholesalers, such as Costco (COST). "They didn't approach Columbia," says Wilmoth. "Columbia's workers requested Safeskin products." According to the analyst, the deal with Columbia lasts six years and has just begun. <snip> Last year, only 13% of company sales came from outside the U.S. -- mostly Europe. Practically speaking -- with less than $25 million in sales -- Europe is still untouched. However, today the company is still trying to build enough capacity to meet U.S. demand. Safeskin is moving up from a run-rate of 3.5 billion gloves annually today to 5 billion by the end of 1998, according to a company spokesman. Chief financial officer David Morash said the firm will continue to expand capacity next year as well. The goal: a run rate of 8 billion gloves per year by the end of the second quarter of 1999. <snip> The company should grow at about 25% per year over the next five years, so investors can expect to own a piece of a $5 billion company by the end of 2000. However, a suitor could come along and quickly end the suspense for shareholders. One thing's certain: Safeskin would fit a giant medical-supply company -- pardon the expression -- like a glove.